BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 6273710)

  • 1. Cellular compartments of GABA in brain and their relationship to anticonvulsant activity.
    Iadarola MJ; Gale K
    Mol Cell Biochem; 1981 Sep; 39():305-29. PubMed ID: 6273710
    [No Abstract]   [Full Text] [Related]  

  • 2. Seizure protection and increased nerve-terminal GABA: delayed effects of GABA transaminase inhibition.
    Gale K; Iadarola MJ
    Science; 1980 Apr; 208(4441):288-91. PubMed ID: 6768130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic utilization of GABA in substantia nigra: regulation by dopamine and GABA in the striatum, and its clinical and behavioral implications.
    Gale K; Casu M
    Mol Cell Biochem; 1981 Sep; 39():369-405. PubMed ID: 6118827
    [No Abstract]   [Full Text] [Related]  

  • 4. Intracerebral injection of gamma vinyl GABA: method for measuring rates of GABA synthesis in specific brain regions in vivo.
    Casu M; Gale K
    Life Sci; 1981 Aug; 29(7):681-8. PubMed ID: 7278507
    [No Abstract]   [Full Text] [Related]  

  • 5. Differential effects of vigabatrin, gamma-acetylenic GABA, aminooxyacetic acid, and valproate on levels of various amino acids in rat brain regions and plasma.
    Löscher W; Hörstermann D
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Mar; 349(3):270-8. PubMed ID: 8208305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The novel antiepileptic drug levetiracetam (ucb L059) induces alterations in GABA metabolism and turnover in discrete areas of rat brain and reduces neuronal activity in substantia nigra pars reticulata.
    Löscher W; Hönack D; Bloms-Funke P
    Brain Res; 1996 Oct; 735(2):208-16. PubMed ID: 8911659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of single and multiple increasing doses of vigabatrin on brain GABA metabolism and correlation with vigabatrin plasma concentration.
    Valdizán EM; Armijo JA
    Biochem Pharmacol; 1992 May; 43(10):2143-50. PubMed ID: 1599502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of microinjections of gamma-vinyl GABA or isoniazid into substantia nigra on the development of amygdala kindling in rats.
    Löscher W; Czuczwar SJ; Jäckel R; Schwarz M
    Exp Neurol; 1987 Mar; 95(3):622-38. PubMed ID: 3817084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental studies of the influence of vigabatrin on the GABA system.
    Gram L; Larsson OM; Johnsen A; Schousboe A
    Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):13S-17S. PubMed ID: 2757904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of content with synthesis, uptake and breakdown of GABA in substantia nigra of unoperated, hemitransected and kainate-treated rats.
    Starr M; Kilpatrick I
    Life Sci; 1981 Nov; 29(22):2281-7. PubMed ID: 7321760
    [No Abstract]   [Full Text] [Related]  

  • 11. Valproate enhances GABA turnover in the substantia nigra.
    Löscher W
    Brain Res; 1989 Oct; 501(1):198-203. PubMed ID: 2508993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron concentration reduced in ventral pallidum, globus pallidus, and substantia nigra by GABA-transaminase inhibitor, gamma-vinyl GABA.
    Hill JM
    Brain Res; 1985 Sep; 342(1):18-25. PubMed ID: 4041811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticonvulsant and proconvulsant effects of inhibitors of GABA degradation in the amygdala-kindling model.
    Löscher W; Jäckel R; Müller F
    Eur J Pharmacol; 1989 Apr; 163(1):1-14. PubMed ID: 2744084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supersensitivity of substantia nigra pars reticulata neurons to GABAergic drugs after striatal lesions.
    Waszczak BL; Hume C; Walters JR
    Life Sci; 1981 May; 28(21):2411-20. PubMed ID: 6265730
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of the substantia nigra in GABA-mediated anticonvulsant actions.
    Gale K
    Adv Neurol; 1986; 44():343-64. PubMed ID: 3010676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of inhibitors of gamma-aminobutyric acid (GABA) transaminase for the estimation of GABA turnover in various brain regions of rats: a reevaluation of aminooxyacetic acid.
    Löscher W; Hönack D; Gramer M
    J Neurochem; 1989 Dec; 53(6):1737-50. PubMed ID: 2809589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term vigabatrin treatment modifies pentylenetetrazole-induced seizures in mice: focused on GABA brain concentration.
    Świąder MJ; Świąder K; Zakrocka I; Krzyżanowski M; Wróbel A; Łuszczki JJ; Czuczwar SJ
    Pharmacol Rep; 2020 Apr; 72(2):322-330. PubMed ID: 32048251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for the involvement of nigrothalamic GABA neurons in circling behaviour in the rat.
    Kilpatrick IC; Starr MS; James TA; MacLeod NK
    Adv Biochem Psychopharmacol; 1981; 30():205-24. PubMed ID: 7331935
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of GABAergic drugs on the GABA turnover in the substantia nigra and the corpus striatum of the rat.
    Lindgren S
    J Neural Transm; 1987; 69(1-2):33-46. PubMed ID: 3035084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GABAergic regulation of striatal opioid gene expression.
    Reimer S; Höllt V
    Brain Res Mol Brain Res; 1991 Apr; 10(1):49-54. PubMed ID: 1647482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.